ACUTE EXACERBATION OF IDIOPATHIC PULMONARY FIBROSIS
Clinical trials for ACUTE EXACERBATION OF IDIOPATHIC PULMONARY FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new ACUTE EXACERBATION OF IDIOPATHIC PULMONARY FIBROSIS trials appear
Sign up with your email to follow new studies for ACUTE EXACERBATION OF IDIOPATHIC PULMONARY FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could steroids save lives during IPF Flare-Ups? new trial aims to find out
Disease control Recruiting nowThis study tests whether a common steroid (glucocorticoid) can reduce deaths in people with idiopathic pulmonary fibrosis (IPF) who experience a sudden, severe worsening of their condition. About 110 adults with IPF and an acute exacerbation will receive either the steroid or a p…
Matched conditions: ACUTE EXACERBATION OF IDIOPATHIC PULMONARY FIBROSIS
Phase: PHASE3 • Sponsor: Fondation Hôpital Saint-Joseph • Aim: Disease control
Last updated May 17, 2026 04:13 UTC
-
Could a common immune treatment save lives during sudden lung scarring attacks?
Disease control Recruiting nowThis study tests whether adding intravenous immunoglobulin (IVIG) to standard care helps people hospitalized with sudden, severe worsening of idiopathic pulmonary fibrosis (IPF). About 196 adults with IPF and an acute flare-up will receive either usual treatment alone or usual tr…
Matched conditions: ACUTE EXACERBATION OF IDIOPATHIC PULMONARY FIBROSIS
Phase: PHASE3 • Sponsor: Argyrios Tzouvelekis • Aim: Disease control
Last updated May 11, 2026 20:40 UTC